||EPS - Basic
||Market Cap (m)
|Pharmaceuticals & Biotechnology
Valirx Share Discussion Threads
Showing 18851 to 18869 of 18875 messages
|What's your thoughts on spsy?Surely we are still too cheap?Yield 9 pct and got cash in bank with growth in most of the businesses|
|Yes me to. It would be good to know Rainmaker is OK
He would not be too happy about Asian Citrus but must be pleased with SPSY.
Simon Thompson must be pretty happy with this years bargain shares. Chariot has more than doubled since February.|
|That's v worrying Really hope his health is ok Miss him One of life's winners|
|Rainmaker no posts since last July i think
hope he is okay|
|no rainmaker and even patviera has disappeared|
|K9pHave some respectYou like many here have lost fortunes hereHow ever respect the individual Bossman is a good guyApologise for being so rude|
Opinion: No Opinion
Which wayToday 10:11If you can't buy mkt must be about to move but which way? As we seem to be in the correct consensus price range.
Dont know who the guy deals with but with iwebsharedealing you can buy any amount @2.42p..|
|Where is rainmaker?Anyone one a view spsy?|
|Soon be Q2 and what info can we expect to hear from the company ..??
Other bio's seem to be moving forward..
ANGLE plc (AIM:AGL OTCQX:ANPCY), the specialist medtech company, is delighted to announce that researchers from the Barts Cancer Institute (BCI), Queen Mary University of London, have presented new results at the World CDx Europe 2017 conference in London of their work with ANGLE's Parsortix system in prostate cancer. The new findings suggest a broader range of potential applications for Parsortix in prostate cancer from early to late disease prognosis.
Oxford, UK - 30 March 2017: Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE:OXB), a leading gene and cell therapy group, is pleased to note the announcement by Novartis that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) filing and granted priority review for CTL019 (tisagenlecleucel-T), an investigational chimeric antigen receptor T cell (CAR-T) therapy, in relapsed and refractory (r/r) pediatric and young adult patients with B-cell acute lymphoblastic leukemia (ALL). The priority review designation is expected to shorten the anticipated review time by the FDA.
GM IN THE STATES...2016 List only on pdf cannot find 2017 list..
Valirx Finland ..........Stand............... 2606
|Our system's recommendation today is to BUY. The pattern finally received a confirmation because the prices crossed above the confirmation level which was at 7.13, and our valid average buying price stands now at 7.17. The previous SELL signal was issued on 21/03/2017, 8 days ago, when the stock price was 9.73. Since then GLR.L has fallen by -26.29%.Market Outlook Let's jump on our white horses and go for a bullish ride. The bullish pattern that was previously identified is finally confirmed and a BUY signal is generated. Most probably, it is the right time to participate in bullish fervor. The market is telling you about a new profit. Do not miss this bullish opportunity. more...|
|More bad language from the local troll .....|
|Most of the trades look like buys but we are red..???|
|So n news and stable price. News good then down it goes . So no news then I guess|
|Famous quote"News is the life blood of the stocketmarket,without it we have no stockmarket"So come on valirx pull your fingers out and give us that important update that we need to more forward or collapse..|
|JG...Surely with all the money you have invested in valirx you have spoken or emailed them with your concerns or spoken to them at one of the presentations you have been too especially if you are concerned about the BoD.?
Opinion: No Opinion
View Thread (2)RE: Trial updatesToday 12:59Best to think of this as a therapy group, as we all suffer from the same ailment. Belief in the product line, which has thus far failed to deliver commercially.
My "belief" in the product line remains the same. But my trust in the BoD is in real question.|
You get the email I sent you today? Check the junk folder, my email account gone off the air!
Hope Valirx produces something extraordinary and becomes the next 50 bagger for all you Chaps! !
My company Paragon Resources is down the tubes. ... Bad management!.., bunch of liars and crooks! .... Oh well! 13 months without a news update|
|Valirx Down today but not out...
|Caut..so do i or its the poor house for me..we need some major updates to stoke up the market but i doubt we will get them..|